Since the use of γ-secretase inhibitors to inhibit Aβ generation has largely failed clinically,55 alternative strategies such as targeting PS1/TREM2 trafficking may be more effective in reversing cognitive decline near the onset of AD. This evidence concerns the gene TREM2 and Alzheimer disease.